Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
M. Glikson
Observed names:
M Glickson,
M. Glickson,
M. Glixon,
Michael Glickson,
Michael Glikson
Institution:
Sheba Medical Center
Observed institutions:
Mayo Clinic,
Tel Aviv University,
Sheba Medical Center,
Hadassah Medical Center,
Amphia Ziekenhuis,
Weizmann Institute of Science
show all 6
OpenAlex ID:
A5044387874
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy
2010
·
Luigi Padeletti
, David O. Arnar
, et al.
·
EP Europace
·
380
PDF
Failure of Long-term Digitalization to Prevent Rapid Ventricular Response in Patients with Paroxysmal Atrial Fibrillation
1991
·
Eithan Galun
, Moshe Y. Flugelman
, et al.
·
CHEST Journal
·
60
A prospective randomized trial of single- or dual-chamber implantable cardioverter-defibrillators to minimize inappropriate shock risk in primary sudden cardiac death prevention
2014
·
P. A. Friedman
, D. Bradley
, et al.
·
EP Europace
·
52
PDF
The effect of electronic repositioning on left ventricular pacing and phrenic nerve stimulation
2011
·
J. Champagne
, J. S. Healey
, et al.
·
EP Europace
·
36
The European cardiac resynchronization therapy survey: patient selection and implantation practice vary according to centre volume
2011
·
N. Bogale
, S. Priori
, et al.
·
EP Europace
·
31
PDF
The effects of anodal stimulation on electrocardiogram, left ventricular dyssynchrony, and acute haemodynamics in patients with biventricular pacemakers
2011
·
R. Abu Sham'a
, R. Kuperstein
, et al.
·
EP Europace
·
24
PDF
Extraction of superfluous device leads: A comparison with removal of infected leads
2015
·
Xin-Miao Huang
, Haixia Fu
, et al.
·
Heart Rhythm
·
22
Safety and efficacy of strategic implantable cardioverter-defibrillator programming to reduce the shock delivery burden in a primary prevention patient population
2013
·
J. Buber
, D. Luria
, et al.
·
EP Europace
·
16
PDF
Familial Budd-Chiari syndrome due to membranous obstruction of the right hepatic vein treated with transluminal angioplasty.
1990
·
R D Feigin
, M Glickson
, et al.
·
PubMed
·
12
Morphological features of the P-waves at surface electrocardiogram as surrogate to mechanical function of the left atrium following a successful modified maze procedure
2013
·
J. Buber
, D. Luria
, et al.
·
EP Europace
·
11
PDF
EHRA Expert Consensus Statement on the management of cardiovascular implantable electronic devices in patients nearing end of life or requesting withdrawal of therapy
2011
·
L. Padeletti
, D. O. Arnar
, et al.
·
EP Europace
·
3
PDF
No hyperglycemia after pyridostigmine administration
1986
·
M. Glickson
, A. Karni
, et al.
·
Journal of Applied Physiology
·
1
P951Death with an implantable cardioverter defibrillator. A MADIT II sub-study
2017
·
F. Chernomordik
, E. Nof
, et al.
·
EP Europace
PDF
Reply to the Editor—Re: Extraction of nonfunctional leads at the time of device upgrade: Still unproven benefit compared to abandoning leads
2015
·
Xin-Miao Huang
, Haixia Fu
, et al.
·
Heart Rhythm
P.4.a.002 Retrospective and prospective systematic evaluation of the mental effect of ICD implantation
2012
·
R. Amiaz
, E. Asher
, et al.
·
European Neuropsychopharmacology
[Quality of life in patients with automatic implantable cardioverter defibrillator (AICD)].
2000
·
Y Drory
, M Glickson
·
PubMed
[Permanent pacemakers in the chest X-ray].
1997
·
Y Bar-Dayan
, M Amitai
, et al.
·
PubMed
Olfaction in Prolonged Administration of Pyridostygmine
1989
·
Yehudah Roth
, Michael Glickson
, et al.
·
The Journal of Clinical Pharmacology
Show more works
View as search
Works count:
18
Citation count:
648
H-index:
10
I10-index:
10
Year
Topic
Type
